Review: taking Symbicort and Mucinex together


Summary

Drug interactions are reported among people who take Symbicort and Mucinex together. This review analyzes the effectiveness and drug interactions between Symbicort and Mucinex. It is created by eHealthMe based on reports of 308 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Symbicort and Mucinex >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Symbicort

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. (latest outcomes from Symbicort 24,831 users)

Mucinex

Mucinex has active ingredients of guaifenesin. It is often used in cough. (latest outcomes from Mucinex 5,919 users)

On Aug, 19, 2016

308 people who take Symbicort, Mucinex are studied.


Number of reports submitted per year:

Symbicort and Mucinex drug interactions.

Drug effectiveness over time:

Symbicort:
  • < 1 month: 100.0% - (2 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 100.0% - (2 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Mucinex:
  • < 1 month: 40.0% - (2 of 5 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Symbicort:
  • female: 66.0% - (2 of 3 people)
  • male: 66.0% - (2 of 3 people)
Mucinex:
  • female: 66.0% - (2 of 3 people)
  • male: 33.0% - (1 of 3 people)

Drug effectiveness by age:

Symbicort:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 0.0% - (0 of 1 people)
Mucinex:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (2 of 2 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • asbestosis
  • chronic obstructive pulmonary disease
  • pneumonia
  • emphysema
  • aspartate aminotransferase increased
  • blood creatinine increased
  • blood pressure increased
  • blood urea increased
  • bronchitis chronic
  • chest pain
1 - 6 months:
  • cough
  • dyspnoea
  • candidiasis
  • acne
  • adverse event
  • anxiety
  • asthma
  • back pain
  • body height decreased
  • bronchitis
1 - 2 years:
  • depression
  • dizziness
  • dyspnoea
  • emotional distress
  • fatigue
  • heart injury
  • anxiety
  • breathlessness
  • cough
  • deep vein thrombosis
2 - 5 years:
  • asthma
  • death
  • upper respiratory tract infection
5 - 10 years:
  • asthma
  • death
  • upper respiratory tract infection
not specified:
  • dyspnoea
  • chronic obstructive pulmonary disease
  • pneumonia
  • cough
  • drug ineffective
  • bronchitis
  • pyrexia
  • pain
  • malaise
  • headache

Most common drug interactions by gender *:

female:
  • dyspnoea
  • chronic obstructive pulmonary disease
  • cough
  • drug ineffective
  • pneumonia
  • headache
  • malaise
  • bronchitis
  • pain
  • fatigue
male:
  • pneumonia
  • chronic obstructive pulmonary disease
  • dyspnoea
  • pyrexia
  • bronchitis
  • asthma
  • dizziness
  • cough
  • arthritis
  • lung infection

Most common drug interactions by age *:

2-9:
  • abasia
  • arthralgia
  • bursitis
  • femur fracture
  • pain in extremity
  • stress fracture
  • cardiac disorder
20-29:
  • anaphylactic shock
  • status asthmaticus
  • anaphylactoid reaction
  • blood potassium abnormal
  • depression
  • fatigue
  • headache
  • muscle spasms
  • paraesthesia
  • thirst
30-39:
  • bronchospasm
  • chest discomfort
  • pain
  • feeling jittery
  • anaphylactic reaction
  • cerebrovascular accident
  • circulatory collapse
  • deep vein thrombosis
  • dysarthria
  • dyspnoea
40-49:
  • bronchitis
  • asthma
  • dyspnoea
  • pyrexia
  • headache
  • pain
  • balance disorder
  • drug ineffective
  • drug intolerance
  • ear infection
50-59:
  • pyrexia
  • dyspnoea
  • pneumonia
  • depression
  • lung disorder
  • asthma
  • lung infection
  • back pain
  • bronchitis
  • gastrooesophageal reflux disease
60+:
  • chronic obstructive pulmonary disease
  • dyspnoea
  • drug ineffective
  • pneumonia
  • cough
  • bronchitis
  • pain
  • malaise
  • nausea
  • hypertension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Symbicort and Mucinex?

Can you answer these questions?

More questions for: Symbicort, Mucinex

You may be interested in these reviews

More reviews for: Symbicort, Mucinex

On eHealthMe, Symbicort (budesonide; formoterol fumarate dihydrate) is often used to treat asthma. Mucinex (guaifenesin) is often used to treat cough. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.